Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    James Hagood

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentPediatrics
    Address9500 Gilman Drive #0731
    CA La Jolla 92093
    Phone858-822-7566
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Novel Targeted Therapies for Pulmonary Fibrosis
      NIH P01HL119165Mar 3, 2015 - Feb 29, 2020
      Role: Co-Investigator
      Alveolar DevMAP
      NIH/NHLBI U01HL122626Jun 15, 2014 - Apr 30, 2019
      Role: Principal Investigator
      Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
      NIH/NHLBI R01HL111169Aug 1, 2012 - May 31, 2016
      Role: Principal Investigator
      Childhood Interstitial &Diffuse Lung Disease Scientific Conference
      NIH/NHLBI R13HL114359Jun 1, 2012 - May 31, 2013
      Role: Principal Investigator
      Epigenetic Alterations in IPF Fibroblastic Foci
      NIH/NHLBI R03HL097006May 11, 2009 - Apr 30, 2012
      Role: Principal Investigator
      Regulation of Fibroblast Phenotype in Lung Fibrosis
      NIH/NHLBI R01HL082818Dec 1, 2005 - Jun 30, 2018
      Role: Principal Investigator
      Role of Fibroblast Thy-1 in Pulmonary Fibrosis
      NIH/NHLBI R01HL065348May 22, 2002 - Mar 31, 2006
      Role: Principal Investigator
      FIBROBLAST CD 90 EXPRESSION IN FIBROGENIC SKIN DISORDERS
      NIH/NIAMS R03AR046378Aug 1, 2000 - Jul 31, 2003
      Role: Principal Investigator
      LUNG FIBROBLAST RESPONSES TO FIBRIN/FIBRINOGEN
      NIH/NHLBI K08HL003239Dec 1, 1994 - Nov 30, 1999
      Role: Principal Investigator
      MULTIPURPOSE ARTHRITIS AND MUSCULOSKELETAL DISEASES
      NIH P60AR020614Sep 20, 1977 - Dec 31, 2002
      Role: Co-Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Joshi S, Singh AR, Wong SS, Zulcic M, Jiang M, Pardo A, Selman M, Hagood J, Durden DL. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype. PLoS One. 2017; 12(8):e0182851. PMID: 28817691.
        View in: PubMed
      2. Ardini-Poleske ME, Clark RF, Ansong C, Carson JP, Corley RA, Deutsch GH, Hagood J, Kaminski N, Mariani TJ, Potter SS, Pryhuber GS, Warburton D, Whitsett JA, Palmer SM, Ambalavanan N, LungMAP Consortium T. LungMAP: The Molecular Atlas of Lung Development Program. Am J Physiol Lung Cell Mol Physiol. 2017 Aug 10; ajplung.00139.2017. PMID: 28798251.
        View in: PubMed
      3. Liu X, Wong SS, Taype CA, Kim J, Shentu TP, Espinoza CR, Finley JC, Bradley JE, Head BP, Patel HH, Mah EJ, Hagood J. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution. Lab Invest. 2017 Mar; 97(3):256-267. PMID: 28165468.
        View in: PubMed
      4. Kleyman M, Sefer E, Nicola T, Espinoza C, Chhabra D, Hagood J, Kaminski N, Ambalavanan N, Bar-Joseph Z. Selecting the most appropriate time points to profile in high-throughput studies. Elife. 2017 Jan 26; 6. PMID: 28124972.
        View in: PubMed
      5. Glasser SW, Hagood J, Wong S, Taype CA, Madala SK, Hardie WD. Mechanisms of Lung Fibrosis Resolution. Am J Pathol. 2016 May; 186(5):1066-77. PMID: 27021937; PMCID: PMC4861766 [Available on 05/01/17].
      6. Checa M, Hagood J, Velazquez-Cruz R, Ruiz V, García-De-Alba C, Rangel-Escareño C, Urrea F, Becerril C, Montaño M, García-Trejo S, Cisneros Lira J, Aquino-Gálvez A, Pardo A, Selman M. Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells. PLoS One. 2016; 11(3):e0150383. PMID: 26934369; PMCID: PMC4775036.
      7. Craig VJ, Zhang L, Hagood J, Owen CA. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2015 Nov; 53(5):585-600. PMID: 26121236; PMCID: PMC4742954 [Available on 11/01/16].
      8. Fiore VF, Strane PW, Bryksin AV, White ES, Hagood J, Barker TH. Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction. J Cell Biol. 2015 Oct 12; 211(1):173-90. PMID: 26459603; PMCID: PMC4602038.
      9. Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C, Liptzin DR, Kroehl ME, Deutsch GH, Young LR, Kurland G, Hagood J, Dell S, Trapnell BC, Deterding RR. Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme. Ann Am Thorac Soc. 2015 Oct; 12(10):1498-505. PMID: 26291470; PMCID: PMC4627419 [Available on 10/01/16].
      10. Ebrahim M, Hagood J, Moore J, El-Said H. Bronchoscopic guidance of endovascular stenting limits airway compression. Catheter Cardiovasc Interv. 2015 Apr; 85(5):832-6. PMID: 25504498.
        View in: PubMed
      11. Hagood J. Beyond the genome: epigenetic mechanisms in lung remodeling. Physiology (Bethesda). 2014 May; 29(3):177-85. PMID: 24789982; PMCID: PMC4046816.
      12. Sanders YY, Hagood J, Liu H, Zhang W, Ambalavanan N, Thannickal VJ. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. Eur Respir J. 2014 May; 43(5):1448-58. PMID: 24603818.
        View in: PubMed
      13. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood J, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med. 2014 Jan 15; 189(2):214-22. PMID: 24160862; PMCID: PMC3983890.
      14. Leyton L, Hagood J. Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions. Adv Neurobiol. 2014; 8:3-20. PMID: 25300130.
        View in: PubMed
      15. Ross MK, Ellis LS, Bird LM, Hagood J. Pulmonary interstitial glycogenosis in a patient ultimately diagnosed with Noonan syndrome. Pediatr Pulmonol. 2014 May; 49(5):508-11. PMID: 24039098.
        View in: PubMed
      16. Harris WT, Kelly DR, Zhou Y, Wang D, MacEwen M, Macewen M, Hagood J, Clancy JP, Ambalavanan N, Sorscher EJ. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. PLoS One. 2013; 8(8):e70196. PMID: 23950911; PMCID: PMC3741283.
      17. Kurland G, Deterding RR, Hagood J, Young LR, Brody AS, Castile RG, Dell S, Fan LL, Hamvas A, Hilman BC, Langston C, Nogee LM, Redding GJ. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013 Aug 01; 188(3):376-94. PMID: 23905526; PMCID: PMC3778735.
      18. Hamvas A, Deterding R, Balch WE, Schwartz DA, Albertine KH, Whitsett JA, Cardoso WV, Kotton DN, Kourembanas S, Hagood J. Diffuse lung disease in children: summary of a scientific conference. Pediatr Pulmonol. 2014 Apr; 49(4):400-9. PMID: 23798474; PMCID: PMC4145861.
      19. Stokes DC, McBride JT, Hagood J, Lesser DJ, Taylor JB. The (pediatric pulmonary) world is flat. The spread of Internet-based pediatric pulmonary case conferences. Ann Am Thorac Soc. 2013 Jun; 10(3):274-5. PMID: 23802832.
        View in: PubMed
      20. Bradley JE, Chan JM, Hagood J. Effect of the GPI anchor of human Thy-1 on antibody recognition and function. Lab Invest. 2013 Mar; 93(3):365-74. PMID: 23358110.
        View in: PubMed
      21. Hagood J, Ambalavanan N. Systems biology of lung development and regeneration: current knowledge and recommendations for future research. Wiley Interdiscip Rev Syst Biol Med. 2013 Mar-Apr; 5(2):125-33. PMID: 23293056.
        View in: PubMed
      22. Dell S, Cernelc-Kohan M, Hagood J. Diffuse and interstitial lung disease and childhood rheumatologic disorders. Curr Opin Rheumatol. 2012 Sep; 24(5):530-40. PMID: 22820514.
        View in: PubMed
      23. Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A, Selman M. Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012 Aug 15; 303(4):L295-303. PMID: 22707614.
        View in: PubMed
      24. Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood J. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):525-35. PMID: 22700861; PMCID: PMC3480526.
      25. Thannickal VJ, Hagood J. Biological insights from clinical trials and networks. Am J Respir Crit Care Med. 2012 Mar 01; 185(5):475-6. PMID: 22383567; PMCID: PMC3297100.
      26. Varisco BM, Ambalavanan N, Whitsett JA, Hagood J. Thy-1 signals through PPAR? to promote lipofibroblast differentiation in the developing lung. Am J Respir Cell Mol Biol. 2012 Jun; 46(6):765-72. PMID: 22268140; PMCID: PMC3380285.
      27. Huang WT, Vayalil PK, Miyata T, Hagood J, Liu RM. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis. Am J Respir Cell Mol Biol. 2012 Jan; 46(1):87-95. PMID: 21852684; PMCID: PMC3262658.
      28. Nuovo GJ, Hagood J, Magro CM, Chin N, Kapil R, Davis L, Marsh CB, Folcik VA. The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis. Mod Pathol. 2012 Mar; 25(3):416-33. PMID: 22037258; PMCID: PMC3270219.
      29. Kis K, Liu X, Hagood J. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med. 2011 Aug 23; 13:e27. PMID: 21861939.
        View in: PubMed
      30. Ramírez G, Hagood J, Sanders Y, Ramírez R, Becerril C, Segura L, Barrera L, Selman M, Pardo A. Absence of Thy-1 results in TGF-ß induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab Invest. 2011 Aug; 91(8):1206-18. PMID: 21577212.
        View in: PubMed
      31. Sanders YY, Tollefsbol TO, Varisco BM, Hagood J. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol. 2011 Jul; 45(1):16-23. PMID: 20724553; PMCID: PMC3145068.
      32. Shan B, Hagood J, Zhuo Y, Nguyen HT, MacEwen M, Morris GF, Lasky JA. Thy-1 attenuates TNF-alpha-activated gene expression in mouse embryonic fibroblasts via Src family kinase. PLoS One. 2010 Jul 19; 5(7):e11662. PMID: 20657842; PMCID: PMC2906514.
      33. Hardie WD, Hagood J, Dave V, Perl AK, Whitsett JA, Korfhagen TR, Glasser S. Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle. 2010 Jul 15; 9(14):2769-76. PMID: 20676040; PMCID: PMC3040960.
      34. Zhou Y, Hagood J, Lu B, Merryman WD, Murphy-Ullrich JE. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem. 2010 Jul 16; 285(29):22382-93. PMID: 20463011; PMCID: PMC2903374.
      35. Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood J, Forman HJ, Thannickal VJ, Postlethwait EM. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem. 2010 May 21; 285(21):16239-47. PMID: 20228065; PMCID: PMC2871491.
      36. McDougal J, Gettys A, Hagood J. ChILD Family Education. Pediatr Allergy Immunol Pulmonol. 2010 Mar; 23(1):87-90. PMID: 22332033.
        View in: PubMed
      37. Deterding RR, Brody AS, Hagood J, Young LR. Round Table Discussion: Children's Interstitial Lung Disease. Pediatr Allergy Immunol Pulmonol. 2010 Mar; 23(1):91-96. PMID: 22332034.
        View in: PubMed
      38. Glasser SW, Hardie WD, Hagood J. Pathogenesis of Interstitial Lung Disease in Children and Adults. Pediatr Allergy Immunol Pulmonol. 2010 Mar; 23(1):9-14. PMID: 22087431.
        View in: PubMed
      39. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009 Aug; 28(8):693-6. PMID: 19633515.
        View in: PubMed
      40. Hardie WD, Glasser SW, Hagood J. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol. 2009 Jul; 175(1):3-16. PMID: 19497999; PMCID: PMC2708789.
      41. Bradley JE, Ramirez G, Hagood J. Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype. Biofactors. 2009 May-Jun; 35(3):258-65. PMID: 19422052.
        View in: PubMed
      42. Nicola T, Hagood J, James ML, Macewen MW, Williams TA, Hewitt MM, Schwiebert L, Bulger A, Oparil S, Chen YF, Ambalavanan N. Loss of Thy-1 inhibits alveolar development in the newborn mouse lung. Am J Physiol Lung Cell Mol Physiol. 2009 May; 296(5):L738-50. PMID: 19270178; PMCID: PMC2681351.
      43. Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood J, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Proc Am Thorac Soc. 2009 Jan 15; 6(1):1-10. PMID: 19131525.
        View in: PubMed
      44. Abman S, Jobe A, Chernick V, Blaisdell C, Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood J, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ, Gail D, Hamvas A, Kercsmar C, Kiley J, Weinmann G. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol. 2009 Jan; 44(1):2-13. PMID: 19086051; PMCID: PMC2778243.
      45. Shaik SS, Soltau TD, Chaturvedi G, Totapally B, Hagood J, Andrews WW, Athar M, Voitenok NN, Killingsworth CR, Patel RP, Fallon MB, Maheshwari A. Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38{beta} MAPK-NF-{kappa}B pathway. J Biol Chem. 2009 Feb 27; 284(9):5945-55. PMID: 19117939; PMCID: PMC2645838.
      46. Zhou Y, Koli K, Hagood J, Miao M, Mavalli M, Rifkin DB, Murphy-Ullrich JE. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin. Am J Pathol. 2009 Jan; 174(1):21-33. PMID: 19056849; PMCID: PMC2631315.
      47. Barker TH, Hagood J. Getting a grip on Thy-1 signaling. Biochim Biophys Acta. 2009 May; 1793(5):921-3. PMID: 19007822; PMCID: PMC2701903.
      48. Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood J. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008 Nov; 39(5):610-8. PMID: 18556592; PMCID: PMC2574530.
      49. Ambalavanan N, Nicola T, Hagood J, Bulger A, Serra R, Murphy-Ullrich J, Oparil S, Chen YF. Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol. 2008 Jul; 295(1):L86-95. PMID: 18487357; PMCID: PMC2494779.
      50. Hagood J, Olman MA. Muscle fatigue: MK2 signaling and myofibroblast differentiation. Am J Respir Cell Mol Biol. 2007 Nov; 37(5):503-6. PMID: 17940320; PMCID: PMC2720146.
      51. Rege TA, Pallero MA, Gomez C, Grenett HE, Murphy-Ullrich JE, Hagood J. Thy-1, via its GPI anchor, modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization, and fibroblast migration, in response to thrombospondin-1/hep I. Exp Cell Res. 2006 Nov 15; 312(19):3752-67. PMID: 17027000.
        View in: PubMed
      52. Sanders YY, Kumbla P, Hagood J. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):226-35. PMID: 16960126; PMCID: PMC2720117.
      53. Rege TA, Hagood J. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta. 2006 Oct; 1763(10):991-9. PMID: 16996153; PMCID: PMC1781924.
      54. Rege TA, Hagood J. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006 Jun; 20(8):1045-54. PMID: 16770003.
        View in: PubMed
      55. Hagood J, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, Alexander CB, Pardo A, Selman M. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol. 2005 Aug; 167(2):365-79. PMID: 16049324; PMCID: PMC1603564.
      56. Arnold DH, Spiro DM, Desmond RA, Hagood J. Estimation of airway obstruction using oximeter plethysmograph waveform data. Respir Res. 2005 Jun 28; 6:65. PMID: 15985171; PMCID: PMC1168908.
      57. Hagood J, Lenker CV, Thrasher S. A course on the transition to adult care of patients with childhood-onset chronic illnesses. Acad Med. 2005 Apr; 80(4):352-5. PMID: 15793019.
        View in: PubMed
      58. Zhou Y, Hagood J, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol. 2004 Aug; 165(2):659-69. PMID: 15277239; PMCID: PMC1618578.
      59. Barker TH, Grenett HE, MacEwen MW, Tilden SG, Fuller GM, Settleman J, Woods A, Murphy-Ullrich J, Hagood J. Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. Exp Cell Res. 2004 May 01; 295(2):488-96. PMID: 15093746.
        View in: PubMed
      60. Barker TH, Pallero MA, MacEwen MW, Tilden SG, Woods A, Murphy-Ullrich JE, Hagood J. Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression, lipid raft integrity, and Src activation. J Biol Chem. 2004 May 28; 279(22):23510-6. PMID: 15033989.
        View in: PubMed
      61. Hagood J, Mangalwadi A, Guo B, MacEwen MW, Salazar L, Fuller GM. Concordant and discordant interleukin-1-mediated signaling in lung fibroblast thy-1 subpopulations. Am J Respir Cell Mol Biol. 2002 Jun; 26(6):702-8. PMID: 12034569.
        View in: PubMed
      62. Barker TH, Fuller GM, Klinger MM, Feldman DS, Hagood J. Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics. J Biomed Mater Res. 2001 Sep 15; 56(4):529-35. PMID: 11400130.
        View in: PubMed
      63. Hagood J, Lasky JA, Nesbitt JE, Segarini P. Differential expression, surface binding, and response to connective tissue growth factor in lung fibroblast subpopulations. Chest. 2001 Jul; 120(1 Suppl):64S-66S. PMID: 11451929.
        View in: PubMed
      64. Barker TH, Klinger MM, Feldman DS, Fuller GM, Hagood J. Spectrophotometric analysis for determining the average number of poly(ethylene) glycol molecules on PEGylated proteins utilizing a protein digestion step. Anal Biochem. 2001 Mar; 290(2):382-5. PMID: 11237345.
        View in: PubMed
      65. Olman MA, Hagood J, Simmons WL, Fuller GM, Vinson C, White KE. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood. 1999 Sep 15; 94(6):2029-38. PMID: 10477732.
        View in: PubMed
      66. Hagood J, Miller PJ, Lasky JA, Tousson A, Guo B, Fuller GM, McIntosh JC. Differential expression of platelet-derived growth factor-alpha receptor by Thy-1(-) and Thy-1(+) lung fibroblasts. Am J Physiol. 1999 Jul; 277(1 Pt 1):L218-24. PMID: 10409250.
        View in: PubMed
      67. Olman MA, Hagood J, Simmons WL, White KE. Fibrin fragment response elements in the plasminogen activator inhibitor gene. Chest. 1999 Jul; 116(1 Suppl):118S-119S. PMID: 10424630.
        View in: PubMed
      68. Olman MA, Williams WF, Strickland JH, Hagood J, Simmons WL, Rivera KE. Facile purification of fibrinogen fragments using a computer-based model with general applicability to the generation of salt gradients. Protein Expr Purif. 1998 Oct; 14(1):71-8. PMID: 9758753.
        View in: PubMed
      69. Zhang Z, Jones S, Hagood J, Fuentes NL, Fuller GM. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem. 1997 Dec 05; 272(49):30607-10. PMID: 9388192.
        View in: PubMed
      70. Liu Z, Fuentes NL, Jones SA, Hagood J, Fuller GM. A unique transcription factor for the A alpha fibrinogen gene is related to the mitochondrial single-stranded DNA binding protein P16. Biochemistry. 1997 Dec 02; 36(48):14799-806. PMID: 9398201.
        View in: PubMed
      71. Hagood J, Olman MA, Godoy JA, Rivera KE, Fuller GM. Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood. 1996 May 01; 87(9):3749-57. PMID: 8611700.
        View in: PubMed
      72. McIntosh JC, Hagood J, Richardson TL, Simecka JW. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur Respir J. 1994 Dec; 7(12):2131-8. PMID: 7536165.
        View in: PubMed
      James's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _